Mersana Therapeutics Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
0.34
0.01
(3.24%)
Volume:
2,115,347
52 week range:
0.26 - 3.50
Market Cap:
41.751M
Company Description:
Mersana Therapeutics, Inc. develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for ovarian cancer and NSCLC adenocarcinoma.